Sanofi to invite recruitment of phase III study for Accomplia TM.

Published: 2006-03-17 06:55:00

Updated: 2006-03-17 06:55:00

Sanofi-Aventis will conduct clinical studies of "RIO-Asia" and "CRESCENDO" for the total 280 Korean obese patients for the assessment of 'Accomplia TM' (Rimonabant) a new anti-fat therapy especially against the abdominal fat.

Two clinical studies will be the first trial of conducting a large s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK